Ranibizumab for Diabetic Traction Retinal Detachment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)
- Status
- UNKNOWN
- Phase
- PHASE3
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE3
LUCAS (Lucentis Compared to Avastin Study)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE2
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
- Status
- COMPLETED
- Phase
- PHASE2
Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3